Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study.

Makiyama A, Kunieda K, Noguchi M, Kajiwara T, Tamura T, Takeda K, Sugiyama J, Minashi K, Moriwaki T, Sugimoto N, Nagase M, Negoro Y, Tsuda T, Shimodaira H, Okano N, Tsuji A, Sakai D, Yanagihara K, Ueda S, Tamura S, Otsu S, Honda T, Matsushita Y, Okuno T, Kashiwada T, Nozaki A, Ebi M, Okuda H, Shimokawa M, Hironaka S, Hyodo I, Baba E, Boku N, Muro K, Esaki T.

Gastric Cancer. 2018 Jan 20. doi: 10.1007/s10120-018-0797-y. [Epub ahead of print]

PMID:
29353332
2.

Charge and Lattice Fluctuations in Molecule-Based Spin Liquids.

Yamamoto T, Fujimoto T, Naito T, Nakazawa Y, Tamura M, Yakushi K, Ikemoto Y, Moriwaki T, Kato R.

Sci Rep. 2017 Oct 10;7(1):12930. doi: 10.1038/s41598-017-13118-4.

3.

Crystallization and vitrification of electrons in a glass-forming charge liquid.

Sasaki S, Hashimoto K, Kobayashi R, Itoh K, Iguchi S, Nishio Y, Ikemoto Y, Moriwaki T, Yoneyama N, Watanabe M, Ueda A, Mori H, Kobayashi K, Kumai R, Murakami Y, Müller J, Sasaki T.

Science. 2017 Sep 29;357(6358):1381-1385. doi: 10.1126/science.aal3120. Epub 2017 Sep 28.

PMID:
28963251
4.

Influence of body composition on disposition of the highly fat distributed compound as analysed by physiologically based pharmacokinetic (PBPK) modeling and simulation.

Goto A, Tagawa Y, Moriya Y, Sato S, Yamamoto M, Wakabayashi T, Tsukamoto T, DeJongh J, van Steeg TJ, Moriwaki T, Asahi S.

Biopharm Drug Dispos. 2017 Dec;38(9):543-552. doi: 10.1002/bdd.2106. Epub 2017 Nov 9.

PMID:
28948605
5.

Selective cytotoxicity of the anti-diabetic drug, metformin, in glucose-deprived chicken DT40 cells.

Kadoda K, Moriwaki T, Tsuda M, Sasanuma H, Ishiai M, Takata M, Ide H, Masunaga SI, Takeda S, Tano K.

PLoS One. 2017 Sep 19;12(9):e0185141. doi: 10.1371/journal.pone.0185141. eCollection 2017.

6.

Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study.

Moriwaki T, Fukuoka S, Taniguchi H, Takashima A, Kumekawa Y, Kajiwara T, Yamazaki K, Esaki T, Makiyama C, Denda T, Satake H, Suto T, Sugimoto N, Enomoto M, Ishikawa T, Kashiwada T, Sugiyama M, Komatsu Y, Okuyama H, Baba E, Sakai D, Watanabe T, Tamura T, Yamashita K, Gosho M, Shimada Y.

Oncologist. 2018 Jan;23(1):7-15. doi: 10.1634/theoncologist.2017-0275. Epub 2017 Sep 11.

PMID:
28894015
7.

Erratum to: Development of in vivo tissue-engineered microvascular grafts with an ultra small diameter of 0.6 mm (MicroBiotubes): acute phase evaluation by optical coherence tomography and magnetic resonance angiography.

Ishii D, Enmi JI, Moriwaki T, Ishibashi-Ueda H, Kobayashi M, Iwana S, Iida H, Satow T, Takahashi JC, Kurisu K, Nakayama Y.

J Artif Organs. 2017 Dec;20(4):403. doi: 10.1007/s10047-017-0980-7. No abstract available.

PMID:
28785829
8.

Effect of Charged Group Spacer Length on Hydration State in Zwitterionic Poly(sulfobetaine) Brushes.

Higaki Y, Inutsuka Y, Sakamaki T, Terayama Y, Takenaka A, Higaki K, Yamada NL, Moriwaki T, Ikemoto Y, Takahara A.

Langmuir. 2017 Aug 29;33(34):8404-8412. doi: 10.1021/acs.langmuir.7b01935. Epub 2017 Aug 17.

PMID:
28737401
9.

A phase II study of 5-fluorouracil/L-leucovorin/oxaliplatin (mFOLFOX6) in Japanese patients with metastatic or unresectable small bowel adenocarcinoma.

Horimatsu T, Nakayama N, Moriwaki T, Hirashima Y, Fujita M, Asayama M, Moriyama I, Nakashima K, Baba E, Kitamura H, Tamura T, Hosokawa A, Yoshimura K, Muto M.

Int J Clin Oncol. 2017 Oct;22(5):905-912. doi: 10.1007/s10147-017-1138-6. Epub 2017 May 23.

10.

Optical evidence for the spin-state disorder in LaCo1-x Rh x O3.

Terasaki I, Asai S, Taniguchi H, Okazaki R, Yasui Y, Ikemoto Y, Moriwaki T.

J Phys Condens Matter. 2017 May 12;29(23):235802. doi: 10.1088/1361-648X/aa6ebc. [Epub ahead of print]

PMID:
28497775
11.

Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G).

Miura Y, Sukawa Y, Hironaka S, Mori M, Nishikawa K, Tokunaga S, Okuda H, Sakamoto T, Taku K, Nishikawa K, Moriwaki T, Negoro Y, Kimura Y, Uchino K, Shinozaki K, Shinozaki H, Musha N, Yoshiyama H, Tsuda T, Miyata Y, Sugimoto N, Shirakawa T, Ito M, Yonesaka K, Yoshimura K, Boku N, Nosho K, Takano T, Hyodo I.

Gastric Cancer. 2018 Jan;21(1):84-95. doi: 10.1007/s10120-017-0725-6. Epub 2017 May 11.

PMID:
28497176
12.

Successful Long-term Management with a Single Administration of Tri-weekly Nab-paclitaxel in a Patient with Advanced Gastric Cancer with Peritoneal Dissemination.

Matano D, Moriwaki T, Tange Y, Niisato Y, Yamaura M, Nagase M, Suganuma D, Takagi Taketa K, Iwai K, Enami C, Yamamoto Y, Hyodo I.

Intern Med. 2017;56(8):921-923. doi: 10.2169/internalmedicine.56.7783. Epub 2017 Apr 15.

13.

Impact of acute fat mobilisation on the pharmacokinetics of the highly fat distributed compound TAK-357, investigated by physiologically based pharmacokinetic (PBPK) modeling and simulation.

Goto A, Tagawa Y, Moriya Y, Sato S, Furukawa Y, Wakabayashi T, Tsukamoto T, DeJongh J, van Steeg TJ, Moriwaki T, Asahi S.

Biopharm Drug Dispos. 2017 Sep;38(6):373-380. doi: 10.1002/bdd.2075. Epub 2017 May 23.

PMID:
28256717
14.

Probing Structural Perturbation in a Bent Molecular Crystal with Synchrotron Infrared Microspectroscopy and Periodic Density Functional Theory Calculations.

Pejov L, Panda MK, Moriwaki T, Naumov P.

J Am Chem Soc. 2017 Feb 15;139(6):2318-2328. doi: 10.1021/jacs.6b11212. Epub 2017 Feb 6.

PMID:
28075578
15.

Motor evoked potential and voluntary EMG activity after olfactory mucosal autograft transplantation in a case of chronic, complete spinal cord injury: case report.

Iwatsuki K, Tajima F, Sankai Y, Ohnishi YI, Nakamura T, Ishihara M, Hosomi K, Ninomiya K, Moriwaki T, Yoshimine T.

Spinal Cord Ser Cases. 2016 Jan 7;2:15018. doi: 10.1038/scsandc.2015.18. eCollection 2016.

16.

Phosphorylated CIS suppresses the Epo or JAK2 V617F mutant-triggered cell proliferation through binding to EpoR.

Funakoshi-Tago M, Moriwaki T, Ueda F, Tamura H, Kasahara T, Tago K.

Cell Signal. 2017 Feb;31:41-57. doi: 10.1016/j.cellsig.2016.12.008. Epub 2016 Dec 28.

PMID:
28038963
17.

Cytotoxicity of Tirapazamine (3-Amino-1,2,4-benzotriazine-1,4-dioxide)-Induced DNA Damage in Chicken DT40 Cells.

Moriwaki T, Okamoto S, Sasanuma H, Nagasawa H, Takeda S, Masunaga SI, Tano K.

Chem Res Toxicol. 2017 Feb 20;30(2):699-704. doi: 10.1021/acs.chemrestox.6b00417. Epub 2016 Dec 27.

PMID:
27943678
18.

Characterization of Heparan Sulfate Proteoglycan-positive Recycling Endosomes Isolated from Glioma Cells.

Podyma-Inoue KA, Moriwaki T, Rajapakshe AR, Terasawa K, Hara-Yokoyama M.

Cancer Genomics Proteomics. 2016 11-12;13(6):443-452.

19.

Five factors can reconstitute all three phases of microtubule polymerization dynamics.

Moriwaki T, Goshima G.

J Cell Biol. 2016 Nov 7;215(3):357-368. Epub 2016 Oct 31.

20.

Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild-type KRAS colorectal cancer-WJOG 6210G.

Shitara K, Yonesaka K, Denda T, Yamazaki K, Moriwaki T, Tsuda M, Takano T, Okuda H, Nishina T, Sakai K, Nishio K, Tokunaga S, Yamanaka T, Boku N, Hyodo I, Muro K.

Cancer Sci. 2016 Dec;107(12):1843-1850. doi: 10.1111/cas.13098.

21.

In vitro metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blocker.

Yamasaki H, Kawaguchi N, Nonaka M, Takahashi J, Morohashi A, Hirabayashi H, Moriwaki T, Asahi S.

Xenobiotica. 2017 Dec;47(12):1027-1034. doi: 10.1080/00498254.2016.1203505. Epub 2016 Jul 14.

PMID:
27414183
22.

Disposition and metabolism of TAK-438 (vonoprazan fumarate), a novel potassium-competitive acid blocker, in rats and dogs.

Kogame A, Takeuchi T, Nonaka M, Yamasaki H, Kawaguchi N, Bernards A, Tagawa Y, Morohashi A, Kondo T, Moriwaki T, Asahi S.

Xenobiotica. 2017 Mar;47(3):255-266. doi: 10.1080/00498254.2016.1182667. Epub 2016 May 26.

PMID:
27225050
23.

Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G).

Yamazaki K, Nagase M, Tamagawa H, Ueda S, Tamura T, Murata K, Eguchi Nakajima T, Baba E, Tsuda M, Moriwaki T, Esaki T, Tsuji Y, Muro K, Taira K, Denda T, Funai S, Shinozaki K, Yamashita H, Sugimoto N, Okuno T, Nishina T, Umeki M, Kurimoto T, Takayama T, Tsuji A, Yoshida M, Hosokawa A, Shibata Y, Suyama K, Okabe M, Suzuki K, Seki N, Kawakami K, Sato M, Fujikawa K, Hirashima T, Shimura T, Taku K, Otsuji T, Tamura F, Shinozaki E, Nakashima K, Hara H, Tsushima T, Ando M, Morita S, Boku N, Hyodo I.

Ann Oncol. 2016 Aug;27(8):1539-46. doi: 10.1093/annonc/mdw206. Epub 2016 May 13.

PMID:
27177863
24.

A Pilot Clinical Study of Olfactory Mucosa Autograft for Chronic Complete Spinal Cord Injury.

Iwatsuki K, Tajima F, Ohnishi Y, Nakamura T, Ishihara M, Hosomi K, Ninomiya K, Moriwaki T, Yoshimine T.

Neurol Med Chir (Tokyo). 2016 Jun 15;56(6):285-92. doi: 10.2176/nmc.oa.2015-0320. Epub 2016 Apr 6.

25.

Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy.

Moriwaki T, Yamamoto Y, Gosho M, Kobayashi M, Sugaya A, Yamada T, Endo S, Hyodo I.

Br J Cancer. 2016 Apr 12;114(8):881-8. doi: 10.1038/bjc.2016.83. Epub 2016 Mar 31.

26.

Characterization of Transporters in the Hepatic Uptake of TAK-475 M-I, a Squalene Synthase Inhibitor, in Rats and Humans.

Ebihara T, Takeuchi T, Moriya Y, Tagawa Y, Kondo T, Moriwaki T, Asahi S.

Drug Res (Stuttg). 2016 Jun;66(6):316-23. doi: 10.1055/s-0035-1569441. Epub 2016 Mar 24.

PMID:
27011383
27.

Development of in vivo tissue-engineered microvascular grafts with an ultra small diameter of 0.6 mm (MicroBiotubes): acute phase evaluation by optical coherence tomography and magnetic resonance angiography.

Ishii D, Enmi J, Moriwaki T, Ishibashi-Ueda H, Kobayashi M, Iwana S, Iida H, Satow T, Takahashi JC, Kurisu K, Nakayama Y.

J Artif Organs. 2016 Sep;19(3):262-9. doi: 10.1007/s10047-016-0894-9. Epub 2016 Mar 22. Erratum in: J Artif Organs. 2017 Dec;20(4):403.

PMID:
27003431
28.

Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?

Yamada T, Yamamoto Y, Moriwaki T, Hyodo I.

J Gastroenterol. 2016 May;51(5):506-7. doi: 10.1007/s00535-016-1184-2. Epub 2016 Feb 18. No abstract available.

PMID:
26891910
29.

Effect of oxygen pressure during incubation with a (10)B-carrier on (10)B uptake capacity of cultured p53 wild-type and mutated tumor cells: dependency on p53 status of tumor cells and types of (10)B-carriers.

Masunaga S, Tatebe H, Nishimura Y, Tano K, Sanada Y, Moriwaki T, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Maruhashi A, Ono K.

Int J Radiat Biol. 2016;92(4):187-94. doi: 10.3109/09553002.2016.1137104. Epub 2016 Feb 18.

PMID:
26887694
30.

Pharmacokinetics of TAK-475, a Squalene Synthase Inhibitor, in Rats and Dogs.

Ebihara T, Teshima K, Kondo T, Tagawa Y, Moriwaki T, Asahi S.

Drug Res (Stuttg). 2016 Jun;66(6):287-92. doi: 10.1055/s-0035-1569407. Epub 2016 Feb 2.

PMID:
26839207
31.

Successful Treatment with Modified FOLFOX6 and Panitumumab in a Cecal Cancer Patient Undergoing Hemodialysis.

Kobayashi M, Endo S, Hamano Y, Imanishi M, Akutsu D, Sugaya A, Ochi D, Moriwaki T, Hyodo I.

Intern Med. 2016;55(2):127-30. doi: 10.2169/internalmedicine.55.5113. Epub 2016 Jan 15.

32.

Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study).

Nishina T, Moriwaki T, Shimada M, Higashijima J, Sakai Y, Masuishi T, Ozeki M, Amagai K, Negoro Y, Indo S, Denda T, Sato M, Yamamoto Y, Nakajima G, Mizuta M, Takahashi I, Hiroshima Y, Ishida H, Maeba T, Hyodo I.

Clin Colorectal Cancer. 2016 Sep;15(3):236-42. doi: 10.1016/j.clcc.2015.12.001. Epub 2015 Dec 17.

PMID:
26778644
33.

Construction of 3 animal experimental models in the development of honeycomb microporous covered stents for the treatment of large wide-necked cerebral aneurysms.

Nakayama Y, Satow T, Funayama M, Moriwaki T, Tajikawa T, Furukoshi M, Hamano E, Ishi D, Hayashi M, Sugata S, Ishibashi-Ueda H, Takahashi JC.

J Artif Organs. 2016 Jun;19(2):179-87. doi: 10.1007/s10047-015-0879-0. Epub 2016 Jan 7.

PMID:
26742535
34.

Extramedullary Conus Ependymoma Involving a Lumbar Nerve Root with Filum Terminale Attachment.

Moriwaki T, Iwatsuki K, Ohnishi Y, Ninomiya K, Yoshimine T.

Clin Med Insights Case Rep. 2015 Nov 30;8:101-4. doi: 10.4137/CCRep.S24719. eCollection 2015.

35.

S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial.

Hironaka S, Sugimoto N, Yamaguchi K, Moriwaki T, Komatsu Y, Nishina T, Tsuji A, Nakajima TE, Gotoh M, Machida N, Bando H, Esaki T, Emi Y, Sekikawa T, Matsumoto S, Takeuchi M, Boku N, Baba H, Hyodo I.

Lancet Oncol. 2016 Jan;17(1):99-108. doi: 10.1016/S1470-2045(15)00410-6. Epub 2015 Nov 28.

PMID:
26640036
36.

Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson's disease patients.

Araki K, Yagi N, Ikemoto Y, Yagi H, Choong CJ, Hayakawa H, Beck G, Sumi H, Fujimura H, Moriwaki T, Nagai Y, Goto Y, Mochizuki H.

Sci Rep. 2015 Dec 1;5:17625. doi: 10.1038/srep17625.

37.

[Visualization for Traditional Quality Management Techniques--Characterization Method for Spikenard of INUBUSHI SEIYAKU Established in the Edo Period].

Ito K, Inubushi S, Moriwaki T, Matsunaga K, Takahashi K, Ueda T, Hashizume S, Takemoto H, Kobayashi Y, Ota T, Nakamura S, Matsuda H.

Yakushigaku Zasshi. 2015;50(1):89-93. Japanese.

PMID:
26427103
38.
39.

Development of an in vivo tissue-engineered vascular graft with designed wall thickness (biotube type C) based on a novel caged mold.

Furukoshi M, Moriwaki T, Nakayama Y.

J Artif Organs. 2016 Mar;19(1):54-61. doi: 10.1007/s10047-015-0859-4. Epub 2015 Aug 12.

PMID:
26265146
40.

Development of an in vivo tissue-engineered valved conduit (type S biovalve) using a slitted mold.

Funayama M, Furukoshi M, Moriwaki T, Nakayama Y.

J Artif Organs. 2015 Dec;18(4):382-6. doi: 10.1007/s10047-015-0856-7. Epub 2015 Aug 2.

PMID:
26233653
41.

A phase II study of S-1, oxaliplatin, oral leucovorin, and bevacizumab combination therapy (SOLA) in patients with unresectable metastatic colorectal cancer.

Nishina T, Kato T, Yamazaki K, Yoshino T, Miyata Y, Esaki T, Moriwaki T, Boku N, Hyodo I.

Cancer Chemother Pharmacol. 2015 Sep;76(3):547-53. doi: 10.1007/s00280-015-2825-5. Epub 2015 Jul 22.

PMID:
26198316
42.

Efficient Total Synthesis of Bongkrekic Acid and Apoptosis Inhibitory Activity of Its Analogues.

Matsumoto K, Suyama M, Fujita S, Moriwaki T, Sato Y, Aso Y, Muroshita S, Matsuo H, Monda K, Okuda K, Abe M, Fukunaga H, Kano A, Shindo M.

Chemistry. 2015 Aug 3;21(32):11590-602. doi: 10.1002/chem.201501304. Epub 2015 Jun 30.

PMID:
26126659
43.

Isolation of human adult olfactory sphere cells as a cell source of neural progenitors.

Ohnishi Y, Iwatsuki K, Ishihara M, Shikina T, Shinzawa K, Moriwaki T, Ninomiya K, Ohkawa T, Umegaki M, Kishima H, Yoshimine T.

Stem Cell Res. 2015 Jul;15(1):23-9. doi: 10.1016/j.scr.2015.04.006. Epub 2015 Apr 29.

44.

Differences between Cervical Schwannomas of the Anterior and Posterior Nerve Roots in Relation to the Incidence of Postoperative Radicular Dysfunction.

Ohnishi Y, Iwatsuki K, Ohkawa T, Ninomiya K, Moriwaki T, Yoshimine T.

Asian Spine J. 2015 Apr;9(2):263-70. doi: 10.4184/asj.2015.9.2.263. Epub 2015 Apr 15.

45.

An internally and externally validated nomogram for predicting the risk of irinotecan-induced severe neutropenia in advanced colorectal cancer patients.

Ichikawa W, Uehara K, Minamimura K, Tanaka C, Takii Y, Miyauchi H, Sadahiro S, Fujita K, Moriwaki T, Nakamura M, Takahashi T, Tsuji A, Shinozaki K, Morita S, Ando Y, Okutani Y, Sugihara M, Sugiyama T, Ohashi Y, Sakata Y.

Br J Cancer. 2015 May 12;112(10):1709-16. doi: 10.1038/bjc.2015.122. Epub 2015 Apr 16.

46.

Phase I study of gemcitabine, cisplatin, and S-1 combination therapy for patients with untreated advanced biliary tract cancer.

Moriwaki T, Ishida H, Araki M, Endo S, Yoshida S, Kobayashi M, Hamano Y, Sugaya A, Shimoyamada M, Hasegawa N, Imanishi M, Ito Y, Sato D, Hyodo I.

J Hepatobiliary Pancreat Sci. 2015 Sep;22(9):669-74. doi: 10.1002/jhbp.255. Epub 2015 Apr 15.

PMID:
25877225
47.

Bonding and electronic states of boron in silicon nanowires characterized by an infrared synchrotron radiation beam.

Fukata N, Jevasuwan W, Ikemoto Y, Moriwaki T.

Nanoscale. 2015 Apr 28;7(16):7246-51. doi: 10.1039/c5nr00427f.

PMID:
25812173
48.

Olfactory sphere cells are a cell source for γ-aminobutyric acid-producing neurons.

Ohnishi Y, Maruo T, Shinzawa K, Iwatsuki K, Moriwaki T, Oshino S, Kishima H, Yoshimine T.

J Neurosci Res. 2015 Aug;93(8):1293-304. doi: 10.1002/jnr.23585. Epub 2015 Mar 18.

PMID:
25790078
49.

Caenorhabditis elegans EXO-3 contributes to longevity and reproduction: differential roles in somatic cells and germ cells.

Kato Y, Moriwaki T, Funakoshi M, Zhang-Akiyama QM.

Mutat Res. 2015 Feb;772:46-54. doi: 10.1016/j.mrfmmm.2015.01.001. Epub 2015 Jan 16.

PMID:
25772110
50.

Proton beam therapy combined with concurrent chemotherapy for esophageal cancer.

Ishikawa H, Hashimoto T, Moriwaki T, Hyodo I, Hisakura K, Terashima H, Ohkohchi N, Ohno T, Makishima H, Mizumoto M, Ohnishi K, Okumura T, Sakurai H.

Anticancer Res. 2015 Mar;35(3):1757-62.

PMID:
25750339

Supplemental Content

Loading ...
Support Center